Fudan Zhangjiang: Fudan Zhangjiang Voluntary Disclosure Notice on Acceptance of Drug Marketing Applications for Obecholic Acid Tablets to Treat Primary Biliary Cholangitis
Announcement of Fudan Zhangjiang on holding the results briefing for the third quarter of 2024
Fudan Zhangjiang: Fudan Zhangjiang H share announcement
Fudan Zhangjiang: Fudan Zhangjiang H share announcement
Fudan Zhangjiang H-share announcement
Fudan Zhangjiang H-share announcement
Fudan Zhangjiang: Fudan Zhangjiang H share announcement
Fudan Zhangjiang H-share announcement
Fudan Zhangjiang Announcement on Participating in the 2024 Semi-Annual Pharmaceutical and Biological Products Special Group Performance Briefing
Announcement of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.'s special report on the use and placement of fundraising during the first half of 2024.
Announcement of the Resolution of the Sixth Meeting of the Eighth Supervisory Committee of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
Mid-year evaluation report of the 'Improving Efficiency and Returning More' action plan for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. in 2024.
Announcement from Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. regarding the 2024 interim performance presentation.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. announcement listed in Hong Kong.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. announcement listed in Hong Kong.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. announcement listed in Hong Kong.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. announcement listed in Hong Kong.
Announcement on the cancellation of part of the raised funds special account by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
Rules of the Fudan-Zhangjiang Supervisory Board Meeting
Rules of the Shareholders Meeting of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
No Data